Calcium, Bioenergetics, and Parkinson’s Disease
Open accessThe DOI matches its Crossref record; 404 of the 407 references it cites were found in a registry or an index.
Abstract
Degeneration of substantia nigra (SN) dopaminergic (DAergic) neurons is responsible for the core motor deficits of Parkinson’s disease (PD). These neurons are autonomous pacemakers that have large cytosolic Ca2+ oscillations that have been linked to basal mitochondrial oxidant stress and turnover. This review explores the origin of Ca2+ oscillations and their role in the control of mitochondrial respiration, bioenergetics, and mitochondrial oxidant stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Effects of Ca2+ on mitochondrial bioenergetic metabolism and reactive oxygen species (ROS) production. The two primary sources of ATP in neurons are glycolysis and mitochondrial OXPHOS. During pacemaking, Ca2+ entry through Cav1 channels, coupled with CICR through RyRs, generates an elevation in [Ca2+]. Elevated [Ca2+] reaching the mitochondria favors the uptake of substrates by the mitochondria by acting on transporters and carriers on the IMM; Ca2+ taken up by mitochondria through the voltage-dependent anion channel (VDAC) and MCUC increases OXPHOS by enhancing the activity of the TCA cycle and by stimulating ATP synthesis by Complex V. The downside of this stimulation is an increase in the generation of ROS.](https://figures.cochat.ai/paper-figures/43417c2546714b5b8fd39a68f718f2a2/calcium-bioenergetics-and-parkinsons-disease-figure-2.jpg)
![Figure 3 Toxic effects of elevated [Ca2+] in SN DAergic neurons. The engagement of Cav1 channels in pacemaking and the release of Ca2+ through RyRs generate elevated cytosolic Ca2+ levels that increase α-synuclein (αSYN) aggregation, directly or through the activation of calpains; Ca2+-activated calpains can also damage several intracellular proteins. Ca2+ and calpain cleavage can increase or dysregulate tyrosine hydroxylase activity and DA production, and DA oxidation can favor the aggregation of αSYN.](https://figures.cochat.ai/paper-figures/f8532e4531ef46f7b8724d464c53bf55/calcium-bioenergetics-and-parkinsons-disease-figure-3.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dopaminergic neurons are more vulnerable to the age-related loss of mitochondrial function, resulting in bioenergetic stress due to their highly ramified processes that harbour dense mitochondria to sustain energy-requiring processes at distal sites.188”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [188]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
Calcium signalling: dynamics, homeostasis and remodelling
Berridge, M. J., Bootman, M. D., & Roderick, H. L. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1155 · Cited by 5,585
Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415
Clapham, D. E. (2007) · Cell · doi:10.1016/j.cell.2007.11.028 · Cited by 4,175
Parkin is recruited selectively to impaired mitochondria and promotes their autophagy
Narendra, D., Tanaka, A., Suen, D.-F., & Youle, R. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200809125 · Cited by 4,026
Stereotaxic mapping of the monoamine pathways in the rat brain
Ungerstedt, U. (1971) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.1971.tb10998.x · Cited by 3,819
Mitochondria: In Sickness and in Health
Nunnari, J., & Suomalainen, A. (2012) · Cell · doi:10.1016/j.cell.2012.02.035 · Cited by 3,479
PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin
Narendra, D. P., Jin, S. M., Tanaka, A., Suen, D.-F., Gautier, C. A., Shen, J., Cookson, M. R., & Youle, R. J. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000298 · Cited by 2,944
Cited by
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
Mitochondrial Ca2+ Signaling in Health, Disease and Therapy
Modesti, L., Danese, A., Vitto, V. A. M., Ramaccini, D., Aguiari, G., Gafà, R., Lanza, G., Giorgi, C., & Pinton, P. (2021) · Cells · doi:10.3390/cells10061317 · Cited by 130
“Neuronal Ca2+ regulation is extremely important even before the appearance of the pathological characteristics of these diseases [99,102,103].”
BackgroundMachine learning and digital biomarkers can detect early stages of neurodegenerative diseases
Chudzik, A., Śledzianowski, A., & Przybyszewski, A. W. (2024) · Sensors · doi:10.3390/s24051572 · Cited by 122
Ca 2+ channels couple spiking to mitochondrial metabolism in substantia nigra dopaminergic neurons
Zampese, E., Wokosin, D. L., González‐Rodríguez, P., Guzmán, J. N., Tkatch, T., Kondapalli, J., Surmeier, W. C., D’Alessandro, K. B., Stefani, D. D., Rizzuto, R., et al. (2022) · Science Advances · doi:10.1126/sciadv.abp8701 · Cited by 104
“Ca 2+ release by the ER can affect mitochondrial OXPHOS in two ways ( 14 , 43 ).”
InfluentialSelf-citationUnraveling Parkinson’s Disease Neurodegeneration: Does Aging Hold the Clues?
Coleman, C., & Martin, I. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223363 · Cited by 76
“Additionally, dopaminergic neurons may be more vulnerable to age-related loss of mitochondrial function and resulting bioenergetic stress due to their highly ramified processes that harbor dense mitochondria to sustain energy-requiring processes at distal sites [22].”
BackgroundThe Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases
Davis, S. E., Cirincione, A. B., Jiménez-Torres, A. C., & Zhu, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015340 · Cited by 61
“However, while this feature helps SNr neurons to meet energy demands, it puts these neurons at higher risk for mitochondrial stress and ROS [113].”
BackgroundSubcellular and regional localization of mRNA translation in midbrain dopamine neurons
Hobson, B. D., Kong, L., Angelo, M. F., Lieberman, O. J., Mosharov, E. V., Herzog, É., Sulzer, D., & Sims, P. A. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110208 · Cited by 52
“Given the importance of autonomous pacemaking activity and cytosolic Ca2+ oscillations to mDA neuronal physiology (Zampese and Surmeier, 2020), the SNr enrichment of Atp2a3 mRNA, which encodes the sarco/endoplasmic reticulum Ca2+-ATPase isoform 3 (SERCA3), is of particular interest.”
Watanabe, H., Dijkstra, J. M., & Nagatsu, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042009 · Cited by 48
“This Ca 2+ system does not affect the pacemaker frequency of signal spiking, which was shown to be determined by TRPC3 and NALCN channels [99], but improves pacemaking robustness by providing a “feed-forward stimulation” system that ensures a sufficient level of ATP for spiking [81,100].”
The role of the brain renin-angiotensin system in Parkinson´s disease
Labandeira-García, J. L., Labandeira, C. M., Guerra, M. J., & Rodriguez-Perez, A. I. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00410-3 · Cited by 50
“Interestingly, compared to more resistant neurons in other regions of the SN and other brain regions, these most vulnerable neurons in the ventral tier of the SNpc also show lower levels of buffer mechanisms, such as low calbindin levels, to counter-act rising intracellular calcium [121, 122].”
BackgroundMolecular and Cellular Interactions in Pathogenesis of Sporadic Parkinson Disease
Долгачева, Л. П., Зинченко, В. П., & Goncharov, N. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113043 · Cited by 51
Sayyaed, A., Saraswat, N., Vyawahare, N. S., & Kulkarni, A. (2023) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-023-01047-4 · Cited by 44
“PD nonmotor symptoms include difficulties with sleep, anxiety, memory, autonomic nervous system, and the senses (Zampese and Surmeier 2020).”
BackgroundGraves, S. M., Schwarzschild, S. E., Tai, R., Chen, Y., & Surmeier, D. J. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105409 · Cited by 44
“To meet this demand, dopaminergic neurons may increase their pacemaking rate, leading to increased cytosolic Ca2+ oscillations and increased stimulation of mitochondrial oxidative phosphorylation (Szibor et al., 2020; Zampese and Surmeier, 2020).”
BackgroundSelf-citationHuang, L., Zhou, Y., Jiao, D., Ren, J., Qi, Y., Wang, H., Shi, Y., Ding, D., & Xue, X. (2023) · Aggregate · doi:10.1002/agt2.403 · Cited by 42
Bastioli, G., Piccirillo, S., Graciotti, L., Carone, M., Sprega, G., Taoussi, O., Preziuso, A., & Castaldo, P. (2024) · Cells · doi:10.3390/cells13151301 · Cited by 40
“3 becomes more prominent in aging SNpc DA neurons in terms of Ca 2+ influx and supporting rhythmic pacemaking activity [23,29,43,45–47].”
BackgroundNeuronal hyperactivity–induced oxidant stress promotes in vivo α-synuclein brain spreading
Helwig, M., Ulusoy, A., Rollar, A., O’Sullivan, S. A., Lee, S. S. L., Aboutalebi, H., Pinto‐Costa, R., Jevans, B., Klinkenberg, M., & Monte, D. A. D. (2022) · Science Advances · doi:10.1126/sciadv.abn0356 · Cited by 38
“During oxidative phosphorylation (OXPHOS), the flux of electrons through the ETC not only generates the energy gradient needed for adenosine triphosphate (ATP) production but also is accompanied by leakage of superoxide primarily from complex I and complex III ( 24 – 26 ).”
Henderson, M. X., Henrich, M. T., Geibl, F. F., Oertel, W. H., Brundin, P., & Surmeier, D. J. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105687 · Cited by 39
“As in muscle (Diaz-Vegas et al., 2018; Viola et al., 2009), this pathway serves as a feed-forward control mechanism for mitochondrial ATP production that anticipates demand, rather than waiting for ATP levels to fall and disinhibit mitochondrial complex V (Zampese and Surmeier, 2020).”
BackgroundSelf-citationProgressive parkinsonism due to mitochondrial impairment: Lessons from the MitoPark mouse model
Beckstead, M. J., & Howell, R. D. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113707 · Cited by 36
Synaptic Disruption by Soluble Oligomers in Patients with Alzheimer’s and Parkinson’s Disease
Gutierrez, B. A., & Limón, A. (2022) · Biomedicines · doi:10.3390/biomedicines10071743 · Cited by 35
Parkkinen, I., Their, A., Asghar, M. Y., Sree, S., Jokitalo, E., & Airavaara, M. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000701 · Cited by 35
“GPCRs do not flux Ca2+ themselves but via ligands for receptors that release Ca2+ from intracellular stores (Berridge, 1998; Brini et al., 2014; Zampese and Surmeier, 2020).”
BackgroundAGC1 Deficiency: Pathology and Molecular and Cellular Mechanisms of the Disease
Pardo, B., Herrada-Soler, E., Satrústegui, J., Contreras, L., & del Arco, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010528 · Cited by 33
Ortner, N. J. (2021) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2021.636103 · Cited by 36
The yin and yang of mitochondrial Ca2+ signaling in cell physiology and pathology
Filadi, R., & Greotti, E. (2020) · Cell Calcium · doi:10.1016/j.ceca.2020.102321 · Cited by 28
Advances in research on mitochondrial dysfunction in neurodegenerative diseases
Zhang, Y., Li, X., Zhang, Y., & Li, X. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13101-4 · Cited by 27
“However, chronic Ca 2 ⁺ over-load leads to mitochondrial stress, excessive ROS accumulation, dopamine metabolism dysregulation, and abnormal gene expression, ultimately accelerating DAergic neuronal degeneration [124].”
Tapias, V., González-Andrés, P., Fernández-Peña, L., Barbero, A., Núñez, L., & Villalobos, C. (2023) · Antioxidants · doi:10.3390/antiox12061282 · Cited by 23
Lage, L., Rodriguez-Perez, A. I., Villar‐Cheda, B., Labandeira-García, J. L., & Dominguez‐Meijide, A. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00650-0 · Cited by 26
“Con-sistentwiththis,mostvulnerabledopaminergicneuronsintheventraltierof theSNshowhigherlevelsofAT1receptorexpressionandlowerlevelsof calbindin,whichbuffersraisinginintracellularcalcium 13,101,102 , as compared with more resistant neurons in the dorsal tier of the SN and other brain regions.”
Mannal, N., Kleiner, K., Fauler, M., Dougalis, A., Pötschke, C., & Liss, B. (2021) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2021.635050 · Cited by 21
“This activity causes additional metabolic stress, as it is associated, in SN but not in VTA DA neurons, with oscillatory elevated levels of free intracellular Ca2+, due to the activation of voltage-gated Ca2+ channels (Cav) during action potentials (Zamponi et al., 2015; Philippart et al., 2016; Liss and Striessnig, 2…”
BackgroundThe PINK1 repertoire: Not just a one trick pony
Pollock, L., Jardine, J., Urbé, S., & Clague, M. J. (2021) · BioEssays · doi:10.1002/bies.202100168 · Cited by 22
“After briefly describing this pathway, here we will focus on Abbreviations: ETC, electron transport chain; ISR, integrated stress response;MDV, mitochondrial derived vesicle; MERC, mitochondria—endoplasmic reticulum contact; mitAP, mitochondrial antigen presentation; nRCC, nuclear-encoded respiratory chain complex; OM…”
BackgroundInfluentialDu, Y., Lee, Y. B., & Graves, S. M. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108817 · Cited by 15
The Common Denominators of Parkinson’s Disease Pathogenesis and Methamphetamine Abuse
Vincent, B., & Shukla, M. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230907151226 · Cited by 13
“As dopaminergic neurons display large cytosolic Ca 2+ oscillations linked to fundamental mitochondrial oxidative stress and susceptibleness in aging and PD [313], meth-induced vulnerability for calcium-induced neurodegenerative processes is likely to occur.”
BackgroundRobust In Vitro Models for Studying Parkinson’s Disease? LUHMES Cells and SH-SH5Y Cells
Keighron, C. N., Avazzedeh, S., & Quinlan, L. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313122 · Cited by 15
Mustafa, R., Rawas, C., Mannal, N., Kreiner, G., Spittau, B., Kamińska, K., Yilmaz, R., Pötschke, C., Kirsch, J., Liss, B., et al. (2021) · Antioxidants · doi:10.3390/antiox10081284 · Cited by 14
Tubert, C., Zampese, E., Pancani, T., Tkatch, T., & Surmeier, D. J. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106328 · Cited by 13
“…acid cycle (TCA) enzymes and stimulates the production of reducing equivalents for the electron transport chain (ETC) and maintenance of the electrochemical gradient necessary for complex V conversion of ADP to ATP (Duchen, 1992; Kann et al., 2003; Yellen, 2018; Zampese and Surmeier, 2020).”
BackgroundSelf-citationMechanistic model-driven exometabolomic characterisation of human dopaminergic neuronal metabolismPreprint
Preciat, G., Wegrzyn, A. B., Moreno, E. L., Willacey, C. C. W., Modamio, J., Monteiro, F. L., Assal, D. C. E., Schurink, A., Oliveira, M. A. P., Zhang, Z., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.30.450562 · Cited by 13
Lighting Up Ca2+ Dynamics in Animal Models
Redolfi, N., García-Casas, P., Fornetto, C., Sonda, S., Pizzo, P., & Pendin, D. (2021) · Cells · doi:10.3390/cells10082133 · Cited by 11
“, dopaminergic neurons in Parkinson’s disease [7,10] and striatal neurons in Huntington’s disease [11]) or specific brain regions (e.”
BackgroundMorikawa, H., Young, C. C., & Smits, J. A. J. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109290 · Cited by 10
Pilski, A., & Graves, S. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713039 · Cited by 10
Molecular hydrogen therapy: A “democratic” emerging strategy against aging and age-related diseases
Brandi, G., Delbaldo, C., Deserti, M., Relli, V., Rimedio, S., Palloni, A., Deiana, C., Saccoccio, G., Ingenito, R., & Tavolari, S. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102802 · Cited by 11
Erhardt, B., Leal, M. C., Marcora, M. S., Frenkel, L., Bochicchio, P. A., Bodín, D. H., Silva, B. A., Dellepiane, M. R. B., Ferrari, C. C., Allo, M. Á., et al. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15401 · Cited by 9
“…could be explained by the presence of a particular combination of unique features of these neurons, such as broad spikes, calcium (Ca2+)dependent pacemaker activity, low intrinsic Ca2+ buffering and cytosolic Ca2+ oscillations (Amini et al., 1999; Kang & Kitai, 1993; Zampese & Surmeier, 2020).”
BackgroundHenkel, L. M., Kankowski, S., Möllenkamp, T. M., Smandzich, N. J., Schwarz, S. C., Fonzo, A. D., Göhring, G., Höglinger, G. U., & Wegner, F. (2023) · Cells · doi:10.3390/cells12020223 · Cited by 9
“Some studies of neurodegenerative diseases and movement disorders describe an increase in basal calcium levels in the affected neuronal cells [16,30,35], whereas we could not observe this in the striatal neurons of the MSA-P patients.”
Romero-Sanz, S., Caldero-Escudero, E., Álvarez-Illera, P., Domingo, J. S., Fonteríz, R. I., Montero, M., & Álvarez, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1182428 · Cited by 10
“There is evidence that alterations in Ca homeostasis may play a relevant role in the neurodegeneration process responsible for PD (Zampese and Surmeier, 2020; Xu et al., 2022).”
BackgroundInsights into Calpain Activation and Rho-ROCK Signaling in Parkinson’s Disease and Aging
Gathings, A., Zaman, V., Banik, N. L., & Haque, A. (2024) · Biomedicines · doi:10.3390/biomedicines12051074 · Cited by 9
“During PD, or the introduction of neurotoxin, oxidative phosphorylation is disrupted, which occurs with an impaired electron transport chain in mitochondria, leading to inhibition of Complex I, reduced production of ATP, and increased calcium concentrations [121–123].”
BackgroundDu, Y., Choi, S., Pilski, A., & Graves, S. M. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.949923 · Cited by 9
“particularly vulnerable to degeneration in Parkinson’s disease (Guzman et al., 2009, 2010, 2018; Goldberg et al., 2012; SanchezPadilla et al., 2014; Surmeier et al., 2017; Gonzalez-Rodriguez et al., 2020; Zampese and Surmeier, 2020).”
BackgroundAn adverse outcome pathway for chemical-induced Parkinson’s disease: Calcium is key
Meerman, J. J., Legler, J., Piersma, A. H., Westerink, R. H. S., & Heusinkveld, H. J. (2023) · NeuroToxicology · doi:10.1016/j.neuro.2023.11.001 · Cited by 9
Wang, Q., Gu, Y., Liu, X., Wang, Q., Xie, C., & Wang, X. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1388226 · Cited by 9
“Disrupted Ca2+ homeostasis and mitochondrial dysfunction are regarded as pivotal factors in the pathophysiology of PD (Guzman et al., 2010; Zaichick et al., 2017; Zampese and Surmeier, 2020).”
BackgroundBeura, S. K., Panigrahi, A. R., Yadav, P., Kulkarni, P. P., Lakhanpal, V., Singh, B., & Singh, S. K. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04589-4 · Cited by 10
“Elevated cytosolic dopamine levels interact with increased Ca 2+ entry and α-synuclein expression, leading to dopamine neurotoxicity in PD [156, 157].”
Thioredoxin‐1 regulates calcium homeostasis in MPP + /MPTP‐induced Parkinson's disease models
Zhang, X., Deng, R., Zhang, S., Deng, J., Jia, J., Sun, B., Zhou, X., & Bai, J. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15355 · Cited by 9
“ER stress is a common feature of PD (Mou et al., 2020; Zampese & Surmeier, 2020).”
BackgroundMusthafa, T., Nizami, S. K., Mishra, A., Hasan, G., & Gopurappilly, R. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70059 · Cited by 8
“Hence, the change in mitochondrial Ca 2+ could be either due to the change in Δψ m or due to the impaired SOCE, which is the main source of the mitochondrial Ca 2+ (Chiu et al. 2017; Ke et al. 2020; Kinghorn et al. 2015; Marchetti et al. 2020; Scorziello et al. 2020; Zampese and Surmeier 2020).”
Grass, L., Grimaldi, S., & Damier, P. (2025) · Revue Neurologique · doi:10.1016/j.neurol.2025.06.012 · Cited by 9
Carneiro-Pereira, B., Ferreira-Antunes, F., Campos, J., Salgado, A. J., & Sampaio‐Marques, B. (2025) · Molecules · doi:10.3390/molecules30112260 · Cited by 6
“These neurons use L-type voltage-gated calcium channels (particularly Ca v 1.3) to generate rhythmic electrical activity, which makes them uniquely dependent on tightly regulated calcium influx [56,57].”
InfluentialCalcium Channels and Selective Neuronal Vulnerability in Parkinson’s Disease
Liss, B., & Surmeier, D. J. (2022) · Springer eBooks · doi:10.1007/978-3-031-08881-0_22 · Cited by 8
Self-citationInsights into PINK1/Parkin function and dysfunction from Drosophila models
Park, S., Kozhushko, N., Wight, T. H., & Whitworth, A. J. (2025) · Biochemical Journal · doi:10.1042/bcj20253459 · Cited by 6
“In this context, disrupted Ca 2+ homeostasis has long been implicated, but links to PINK1/ Parkin function and dysfunction have been rather underexplored [149,150].”
Basu, S., Dudhabhate, B. B., Mitra, S., Srivastava, A., Pradhan, P., Goswami, C., Kokare, D. M., & Singru, P. S. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110545 · Cited by 5
Han, B., & Bai, J. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04591-9 · Cited by 4
“3 antagonists provide neuroprotection in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine ( MPTP) and rotenone (ROT) induced PD models [33].”
Disease mechanisms as Subtypes: Mitochondrial and bioenergetic dysfunction
González‐Rodríguez, P., Zampese, E., & Surmeier, D. J. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85555-6.00007-2 · Cited by 5
Self-citationChiu, W., Wattad, N., & Goldberg, J. A. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108683 · Cited by 4
Ji, Y., Xu, M., Zhao, H., Cai, H., Chen, K., Zhang, L., Mao, H., Wang, F., Zhu, J., & Fang, X. (2025) · Cerebral Cortex · doi:10.1093/cercor/bhaf097 · Cited by 6
Gene therapy for Parkinson’s disease—Ample room for optimism
Sandoval, I. M., Salvatore, M. F., & Manfredsson, F. P. (2025) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2025.103150 · Cited by 3
Tchung, A., Even, A., & Trudeau, L. (2026) · Trends in Neurosciences · doi:10.1016/j.tins.2026.02.003 · Cited by 4
Is There a Better Way to Assess Parkinsonian Motor Symptoms?—Experimental and Modelling Approach
Nair, S. S., Muddapu, V. R., Sriram, M., Aditya, R., Gupta, R., & Chakravarthy, V. S. (2021) · Series in bioengineering · doi:10.1007/978-981-16-3056-9_10 · Cited by 6
Key Signalling Molecules in Aging and Neurodegeneration
Filadi, R., & Pizzo, P. (2022) · Cells · doi:10.3390/cells11050834 · Cited by 3
“Dysregulation of this latter is a typical trait observed in different neurodegenerative and aging-related disorders, ranging from PD (where it is associated with alterations of neuronal Ca2+ homeostasis, as described by Enrico Zampese and James Surmeier [13]), to AD (see below) and aging-related sarcopenia, as reporte…”
BackgroundDesai, D. A., Majrashi, M., Pathak, S., Almaghrabi, M., Liu, K., Pondugula, S. R., Tiwari, A. K., Babu, R. J., DeRuiter, J., & Dhanasekaran, M. (2024) · Cancer Reports · doi:10.1002/cnr2.2074 · Cited by 3
“42 Chemotherapeutics-related cognitive impairment (CRCI) has become an area of great research interest in the past few years.”
BackgroundFrom Stress to Neurodegeneration: A New Look at the Pathogenesis of Parkinson’s Disease
Kazanskaya, R. B., Tsytsarev, V., Volnova, A. B., Gainetdinov, R. R., & Lopachev, A. V. (2026) · Biomedicines · doi:10.3390/biomedicines14051130 · Cited by 2
“Oxidative stress is a well-established contributor to neurodegeneration, and neurons— particularly dopaminergic neurons of the substantia nigra—are exceptionally vulnerable due to their high metabolic rate, calcium oscillations, and reliance on reactive oxygen species (ROS) for signaling [148–152].”
Fathi, A., Bakshy, K., Zieghami, L., Fiene, R., Bradley, R., Dickerson, S., Carlson, C. B., Schachtele, S. J., & Liu, J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.06.521264 · Cited by 3
Zampese, E., Moran, J., & Surmeier, D. J. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-29867-7.00039-6 · Cited by 1
Self-citationZeng, F., Li, W., Yang, L., Lu, Y., & Wang, X. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1692777 · Cited by 1
Selective neurodegeneration in patients with parkinson’s disease
Yusupov, F. A., & Abdykadyrov, M. S. (2026) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202612602123 · Cited by 1
A review on the nutraceuticals of Parkinson's disease
Vella, C., & Blundell, R. A. (2024) · Journal of Food Nutrition and Diet Science · doi:10.55976/fnds.22024124151-65 · Cited by 1
“The research highlighted the significance of conducting thorough investigations to ascertain the effectiveness of potential treatments for neurodegenerative diseases [44].”
BackgroundDeviant lysosomal K+ fluxes and Parkinson’s. A calci-centric point of view
Gregori, M., Bolsover, S. R., & Patel, S. (2021) · Cell Calcium · doi:10.1016/j.ceca.2021.102418
Matthes, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00092-x
Waspiah, W. (2009) · Cited by 1
Sharifi, P., Bae, H., Gveric, D. O., Gentleman, S., Smith, P. J., Tierney, T. S., & Alavian, K. N. (2022) · Brain Disorders · doi:10.1016/j.dscb.2022.100031 · Cited by 1
Albin, R. L. (2022) · Oxford University Press eBooks · doi:10.1093/med/9780190843014.003.0007
Calcium Homeostasis in Dopaminergic Neurons
Frank, A. K., Boumhaouad, S., Fanourakis, S., Sulzer, D., & Mosharov, E. V. (2024) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190932183.013.15
Gökçe, E. (2025) · Journal of Ankara University Faculty of Medicine · doi:10.4274/atfm.galenos.2024.15010
Calcium at the crossroads: TPC2’s role in LRRK2-linked Parkinson’s disease
Lazzari, F. D., Wanderoy, S., & Whitworth, A. J. (2025) · Cell Calcium · doi:10.1016/j.ceca.2025.103049
Jenei, G. (2026) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.13003
RNA Splicing Dysregulation in Parkinson’s Disease
Bruno, M. G., Menichetti, G., Valentino, A., Javaid, A., Belpinati, F., Ruggiero, A., Valenti, M. T., Paolone, G., Cavaliere, F., Trabetti, E., et al. (2026) · Genes · doi:10.3390/genes17080911 · Cited by 1
“Their high metabolic demand, extensive axonal network, and continuous electrical activity require large amounts of energy, making them particularly sensitive to mitochondrial dysfunction [178].”
Selective Neurodegeneration in Patients with Parkinson’s Disease
Yusupov, F. A., & Abdykadyrov, M. (2026) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-026-02040-w
“Within the pars compacta of the SN, ventral neurons are especially susceptible and tend to degenerate fi rst [18].”
InfluentialXi, Y.-T., Jia, C.-X., Wang, H. Q., Liu, P., Li, P., Niu, Q., & Yin, Y. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103358 · Cited by 1
Chen, X., Zhao, Z., Shen, Y., Ji, Y., Yao, X., Gu, X., Qi, L., & Sun, H. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.116041
Metadata
- Authors
- Zampese, E., & Surmeier, D. J.
- Affiliations
- Northwestern University (US)
- Corresponding author
- Surmeier, D. James
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-09-08
- Volume
- 9
- Issue
- 9
- Pages
- 2045
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC7564460
- OpenAlex
- W3083790931
- Cited by
- 79
- References
- 407
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 13 · 2023: 13 · 2022: 14 · 2021: 15 · 2020: 1
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute of Neurological Disorders and Stroke (P50NS047085)
- Michael J. Fox Foundation for Parkinson's Research (Surmeier)
- JPB Foundation (Surmeier)
- IDP Foundation (Surmeier)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, calcium oscillations, substantia nigra, dopaminergic neurons, mitochondrial respiration, bioenergetics, neurodegeneration, motor impairment
- MeSH terms
- Calcium, Energy Metabolism, Humans, Parkinson Disease, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.